| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10969727 | Vaccine | 2012 | 10 Pages |
Abstract
⺠Combined RSV antigen/innate ligand adjuvants augments local IgA responses. ⺠Supplementation with innate ligand adjuvants skews towards Th1 responses. ⺠Combined RSV antigen/innate ligand adjuvants provides protection against infection. ⺠Combined RSV antigen/innate ligand adjuvants does not prime for enhanced disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Muhammad Shafique, Jan Wilschut, Aalzen de Haan,